
TRIANA Biomedicines
Operator of a pharmaceutical company intended to discover and develop molecular glues. The company leverages technology to stabilize pre-existing or create de novo interactions between multiple protei...
Valuation
$258M
Latest known
Share Price
N/A
Total Raised
$246.1M
Last Round
N/A